Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

Gut

Volumn 52, Issue 2, 2003, Pages 237-242

  Seksik, P ^b,c,d   Rigottier Gois, L ^b   Gramet, G ^b   Sutren, M ^b   Pochart, P ^c   Marteau, P ^a,d   Jian, R ^d   Dore J ^b  

^a Hop Europ Georges Pompidou   (France)

^b CEMAGREF   (France)

^c Laboratoire de Biologie EA3199   (France)

^d AP HP ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; RIBOSOME DNA; RIBOSOME RNA;

ADULT; AGED; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; BIODIVERSITY; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; COLON; CONTROLLED STUDY; CROHN DISEASE; DOT HYBRIDIZATION; ENTEROBACTERIACEAE; ENTEROCOCCUS; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GEL ELECTROPHORESIS; HUMAN; ISOTOPE LABELING; LACTOBACILLUS; MALE; PHYLOGENY; PORPHYROMONAS; PRIORITY JOURNAL; REMISSION; STREPTOCOCCUS;

ADOLESCENT; ADULT; AGED; BACTERIA; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; COLITIS; CROHN DISEASE; DNA, BACTERIAL; DNA, RIBOSOMAL; ENTEROBACTERIACEAE; FECES; FEMALE; HUMANS; ILEITIS; LACTOBACILLUS; MALE; MIDDLE AGED; RNA, BACTERIAL; RNA, RIBOSOMAL;

EID: 0037302961     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.2.237     Document Type: Article

References (42)

1. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997;148:567-76.
2. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
3. Rutgeerts P, Geboes K, Peeters M, et al. Effect of the faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
4. Harper PH, Lee EC, Kettlewell MG, et al. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985;26:279-84.
5. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35.
6. Marteau PR, de Vrese M, Cellier CJ, et al. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001;73:430-6S.
7. Malchow HA. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 1997;25:653-8.
8. Guslandi M, Mezzi G, Sorghi M, et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000;45:1462-4.
9. Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine. Gastroenterology 2000;118:G4179.
10. Doré J, Gramet G, Goderel I, et al. Culture-independent characterisation of human feacal flora using rRNA-targeted hybridization probes. Genet Sel Evol 1998;30:287-96.
11. Doré J, Sghir A, Hannequart-Gramet G, et al. Design and evaluation of a 16S rRNA-targeted oligonucleotide prabe for specific detection and quantitation of human faecal Bacteroides populations. Syst Appl Microbiol 1998;21:65-71.
12. Alm EW, Oerther DB, Larsen N, et al. The oligonucleotide probe database. Appl Environ Microbial 1996;62:3557-9.
13. Zheng D, Alm EW, Stahl DA, et al. Characterization of universal small-subunit rRNA hybridization probes for quantitative molecular microbial ecology studies. Appl Environ Microbiol 1996;62:4504-13.
14. Stahl DA, Amann R. Development and application of nucleic acid probes. In: Stackebrant E, Goodfellow M (eds). Nucleic acid and techniques in bacterial systematics. Chichester: John Wiley and Sons Ltd, 1991:205-48.
15. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854-9.
16. Sutren M, Michel M, de la Cochetièe MF, et al. Temporal temperature gradient gel electrophoresis (TTGE) is an appropriate tool to assess dynamics of species diversity of the human fecal flora. Reprod Nutr Dev 2000;40:176-7.
17. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979;77:843-6.
18. Amann RI, Binder BJ, Olson RJ, et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990;56:1919-25.
19. Franks AH, Harmsen HJ, Raangs GC, et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998;64:3336-45.
20. Sghir A, Gramet G, Suau A, et al. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 2000;66:2263-6.
21. Mangin I, Bouhnik Y, Suau A, et al. Molecular analysis of the intestinal microbiota composition to evaluate the effect of PEG and lactulose laxatives in humans. Microb Ecol Health Dis 2002;14:54-62.
22. Sghir A, Antonopoulos D, Mackie RI. Design and evaluation of a Lactobacillus group-specific ribosomal RNA-targeted hybridization probe and its application to the study of intestinal microecology in pigs. Syst Appl Microbiol 1998;21:291-6.
23. Suau A, Bonnet R, Sutren M, et al. Direct analysis of genes encoding 16S rRNA from camplex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799-807.
24. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-7.
25. Sartor RB. Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream. Gastroenterology 1998;114:398-400.
26. Amann R, Springer N, Ludwig W, et al. Identification in situ and phylogeny of uncultured bacterial endosymbionts. Nature 1991;351:161-4.
27. Stahl DA, Flesher B, Mansfield HR, et al. Use of phylogenetically based hybridization probes for studies of ruminal microbial ecology. Appl Environ Microbiol 1988;54:1079-84.
28. Hartley MG, Hudson MJ, Swarbrick ET, et al. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis. Aliment Pharmacol Ther 1996;10:157-63.
29. Gorbach SL, Nahas L, Plaut AG, et al. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology 1968;54:575-87.
30. Keighley MR, Arabi Y, Dimock F, et al. Influence of inflammatory bowel disease on intestinal microflora. Gut 1978;19:1099-104.
31. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;11:1405-13.
32. Rembacken BJ, Shelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999;354:635-9.
33. Kruis W, Schütz E, Fric P, et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997;11:853-8.
34. Kruis W, Fric P, Stolte M. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1997 and with standard mesalamine. Gastroenterology 2001;120:A139.
35. Rath HC, Ikeda JS, Linde HJ, et al. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1999;116:310-19.
36. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991;35:238-43.
37. Ruseler-van Embden JG, Both-Patoir HC. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek 1983;49:125-32.
38. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999;116:1107-14.
39. O'Mahony L, Feeney M, O'Halloran S, et al. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 2001;15:1219-25.
40. Gupta P, Andrew H, Kirschner BS, et al. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000;31:453-7.
41. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind placebo-controlled trial. Gastroenterology 2000;119:305-9.
42. Favier C, Neut C, Mizon C, et al. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997;42:817-22.